Medicare Enrolled
Dr. Kamyar Ebrahimi, M.D.
Urology Physician · Glendale, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ebrahimi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ebrahimi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ebrahimi
Dr. Kamyar Ebrahimi is an urology physician in Glendale, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ebrahimi performed 4,817 Medicare services across 2,977 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ebrahimi received a total of $15,603 from 54 pharmaceutical and/or device companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ebrahimi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 19% volume in CA
$15,603 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,817
Medicare services
Top 19% in CA for urology physician
2,977
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~268 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,702 | $73 | $170 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
737 | $100 | $220 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
462 | $85 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $98 | $209 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
231 | $134 | $307 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
195 | $109 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 192 | $134 | $250 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
115 | $36 | $220 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
112 | $86 | $220 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
110 | $145 | $310 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
109 | $216 | $350 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
66 | $16 | $30 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
64 | $31 | $85 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
47 | $126 | $280 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
36 | $35 | $180 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
25 | $95 | $960 |
| Prostate tissue destruction using radiofrequency heated water vapor A procedure that destroys prostate tissue by using radiofrequency energy to heat water vapor. This method is applied to treat the prostate gland. |
25 | $1,542 | $5,420 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
23 | $286 | $500 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
21 | $564 | $1,200 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $214 | $350 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
21 | $52 | $395 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
20 | $44 | $200 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
19 | $313 | $1,120 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
18 | $20 | $210 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $93 | $258 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $46 | $132 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
14 | $249 | $900 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
12 | $474 | $1,300 |
| Complicated insertion of bladder tube | 12 | $63 | $350 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
12 | $9 | $65 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
18.5% medium
80.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,603
Total received (2018-2024)
Avg $2,229/year across 7 years
Top 14% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
352
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,817 (88.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,786 (11.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,751
2023
$2,902
2022
$1,386
2021
$1,336
2020
$615
2019
$4,039
2018
$3,575
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$787
Sumitomo Pharma America, Inc.
$197
Astellas Pharma US Inc
$167
Olympus America Inc.
$160
BIOTISSUE HOLDINGS INC.
$90
PFIZER INC.
$88
COLOPLAST CORP
$59
ABBVIE INC.
$33
Merck Sharp & Dohme LLC
$29
Boston Scientific Corporation
$28
PROGENICS PHARMACEUTICALS, INC.
$28
UROGEN PHARMA, INC.
$27
Janssen Biotech, Inc.
$21
Myriad Genetic Laboratories, Inc.
$19
Endo Pharmaceuticals Inc.
$16
Top 3 companies account for 65.8% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$3,047
NeoTract Inc.
$2,582
Astellas Pharma US Inc
$1,623
PFIZER INC.
$1,050
Boston Scientific Corporation
$872
PROCEPT BioRobotics Corporation
$807
Endo Pharmaceuticals Inc.
$464
Dendreon Pharmaceuticals LLC
$457
Coloplast Corp
$386
Bayer HealthCare Pharmaceuticals Inc.
$302
Sumitomo Pharma America, Inc.
$261
Janssen Pharmaceuticals, Inc
$243
Janssen Biotech, Inc.
$224
Olympus America Inc.
$199
COLOPLAST CORP
$190
BIOTISSUE HOLDINGS, INC.
$182
EDAP TECHNOMED INC
$170
Avadel Specialty Pharmaceuticals, LLC
$167
Merck Sharp & Dohme LLC
$164
BioTissue Holdings, Inc.
$162
Myovant Sciences Inc.
$140
Teleflex LLC
$126
Mallinckrodt Enterprises LLC
$125
Amgen Inc.
$120
Myriad Genetic Laboratories, Inc.
$111
AngioDynamics, Inc.
$101
UROVANT SCIENCES INC
$98
Baxter Healthcare
$94
BIOTISSUE HOLDINGS INC.
$90
BAXTER HEALTHCARE
$88
UROGEN PHARMA, INC.
$80
Blue Earth Diagnostics Limited
$66
AstraZeneca Pharmaceuticals LP
$66
Axonics, Inc.
$64
ABBVIE INC.
$61
Janssen Products, LP
$61
UroGen Pharma, Inc.
$58
Merck Sharp & Dohme Corporation
$56
Progenics Pharmaceuticals, Inc.
$51
Rochester Medical Corporation
$49
NxThera, Inc.
$45
MEDIVATION FIELD SOLUTIONS LLC
$33
Lumenis, Inc
$31
ConvaTec Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$28
AbbVie Inc.
$25
Telix Pharmaceuticals
$24
ABC Home Medical Supply, Inc.
$22
Ambu Inc.
$21
Sonex Health, Inc.
$20
KARL STORZ Endoscopy-America
$20
BOSTON SCIENTIFIC CORPORATION
$19
DENTSPLY IH Inc.
$16
BARD PERIPHERAL VASCULAR, INC.
$12
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ALTIS · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Axonics · Axumin · BOTOX · BRIDION · BioSurgery - FLOSEAL · CONTINENCE CARE · COSEAL · Coloplast TFL Drive · Da Vinci Surgical System · ERLEADA · Erleada · FLOSEAL · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · ILLUCCIX · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · LoFric · Lumenis Pulse 120H · MYRBETRIQ · Myrbetriq · NANOKNIFE · NEOX · NanoKnife · Noctiva · Nubeqa · OFIRMEV · ORGOVYX · Olympus Ureteroscopes · PERCLOT · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · Repatha · Restorelle · Rezum · Rezum Generator · SOLTIVE · SPEEDICATH · SpeediCath · Sx-one Microknife · TISSEEL · TOVIAZ · Titan · UROLIFT · UroLift · UroLift System · Veozah · XARELTO · XIAFLEX · XTANDI · Xofigo · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
383
Per 100K population
3.9
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ebrahimi is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ebrahimi experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ebrahimi performed 1,702 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ebrahimi receive payments from pharmaceutical companies?
Yes. Dr. Ebrahimi received a total of $15,603 from 54 companies across 352 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ebrahimi's costs compare to other urology physicians in Glendale?
Dr. Ebrahimi's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ebrahimi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Glendale
Browse urology physicians in Glendale ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology